Dammann H G, Müller P, Simon B
Z Gastroenterol. 1982 Oct;20(10):613-6.
24 hours intragastric acidity was measured in 6 healthy volunteers in 4 separate 24-hours studies, during which the subjects ate Hipp-meals and had unrestricted physical activity. The medication consisted of 1.0 microgram/kg b.w.td p.o. and 0,5 micrograms/ kg b.w. td p.o. of 16,16-dimethyl-PG E2 or placebo. 1.0 microgram/kg b.w. of 16,16-dimethyl-PG E2 decreased mean 24 hours hydrogen ion activity from 9,81 +/- 1,85 mmol/l (+/- SEM) to 4,08 +/- 1,14 mmol/l (+/- SEM). The degree of inhibition with 0,5 micrograms/kg b.w. td was significantly smaller than that due to ten higher dose of this methylated PG-analogue. Our data reveal, that lower doses of 16,16-dimethyl-PG E2 as originally believed inhibit gastric acid secretion in man effectively.
在4项独立的24小时研究中,对6名健康志愿者进行了24小时胃内酸度测量,在此期间,受试者食用希普餐且身体活动不受限制。药物包括口服1.0微克/千克体重每日两次和0.5微克/千克体重每日两次的16,16-二甲基前列腺素E2或安慰剂。1.0微克/千克体重的16,16-二甲基前列腺素E2使平均24小时氢离子活性从9.81±1.85毫摩尔/升(±标准误)降至4.08±1.14毫摩尔/升(±标准误)。0.5微克/千克体重每日两次的抑制程度明显小于该甲基化前列腺素类似物较高剂量时的抑制程度。我们的数据表明,原本认为较低剂量的16,16-二甲基前列腺素E2能有效抑制人体胃酸分泌。